PureTech Health PLC (NAS:PRTC)
$ 20.69 0.65 (3.24%) Market Cap: 485.88 Mil Enterprise Value: -7.42 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 58/100

PureTech Health PLC at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 05:00PM GMT
Release Date Price: $26.3 (-1.90%)
Edwin Zhang
JPMorgan Chase & Co. - Moderator

So good morning. Welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is Edwin Zhang. I'm a member of the JPMorgan healthcare team and the moderator for this session.

Today, I would like to introduce you to the team from PureTech Health. Please join me in welcoming our presenters, Daphne Zohar, Co-Founder and CEO; and Eric Elenko, Co-Founder.

Daphne Zohar
PureTech Health PLC - Founder, Managing Partner, Director

Thanks so much, Edwin, and thank you to the JPMorgan team for inviting us to present today. Welcome to all of you who are joining us here in the room and those of you who are joining us via webcast. We're coming off of a very successful 2023 with strong clinical and strategic progress. And we're at a turning point this year for our company as we sharpen our focus on pulmonary and rare disease in our wholly owned pipeline and as we advance two new founded entities that we'll be saying more about in two important additional therapeutic areas.

We'll be making some forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot